Efficacy and safety of immunosuppressants and immunomodulators in juvenile myasthenia gravis: a systematic review and meta-analysis

作者
Xiaoling Zhong,Yu Xie,Y P. Li,Hua Yang,Rong Luo
出处
期刊:Journal of Translational Medicine [BioMed Central]
卷期号:24 (1) 被引量:3
标识
DOI:10.1186/s12967-026-07925-5
摘要

OBJECTIVE: In the present meta-analysis, we aimed to explore the efficacy and safety of immunosuppressants and immunomodulators for the treatment of juvenile myasthenia gravis (JMG). METHODS: ≥50% or P < 0.05), the random effects model was used; otherwise, the fixed effects model was used to calculate the pooled results. RESULTS: A total of 3029 articles were retrieved. This meta-analysis included 9 cohort and case-control studies, 11 case series, 3 single-arm studies, and 1 randomized controlled trial, focusing on tacrolimus, glucocorticoids, monoclonal antibodies, and intravenous immunoglobulin. Regarding tacrolimus, 9 studies involving 310 patients assessed the efficacy of tacrolimus for treating JMG. The results showed a significant reduction in both the Quantitative Myasthenia Gravis (QMG) and Myasthenia Gravis Activities of Daily Living (MG-ADL) scores. Moreover, tacrolimus treatment allowed for a reduction in steroid dosage, with a response rate of 0.862 (95% CI: 0.716-0.967). For monoclonal antibodies, 6 studies with 67 patients analyzed the efficacy for JMG. The response rate of monoclonal antibodies was 0.993 (95% CI: 0.935-1.000). Descriptive analyses were conducted for glucocorticoids and IVIG. Besides, 5 studies with 348 patients assessed the efficacy of glucocorticoids for JMG. Included studies showed that the efficacy rate of glucocorticoid monotherapy for isolated ocular myasthenia gravis (OMG) was higher than that for patients with both OMG and generalized myasthenia gravis (GMG). Finally, regarding the use of IVIG, 4 studies reported efficacy for JMG. These investigations reported a response rate ranging from 47.06% to 94.3% for IVIG therapy. CONCLUSIONS: In summary, this was the first comprehensive meta-analysis of immunosuppressants and immunomodulators in JMG. However, most included studies were single-center retrospective observational studies. Future prospective multicenter studies are needed to further investigate the efficacy and safety of immunosuppressants and immunomodulators in JMG.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
威武幼荷完成签到 ,获得积分10
1秒前
mufulee完成签到,获得积分10
1秒前
molihuakai的应助被灶鲜森采纳,获得10
2秒前
明理的踏歌完成签到,获得积分0
3秒前
Qps完成签到 ,获得积分10
3秒前
包容雁菡完成签到,获得积分10
3秒前
852的应助被ice采纳,获得10
7秒前
花花子完成签到 ,获得积分10
10秒前
11秒前
369ninja的应助被风格采纳,获得30
13秒前
布曲完成签到 ,获得积分10
14秒前
YZ完成签到 ,获得积分10
14秒前
灶鲜森发布了新的文献求助10
16秒前
lili完成签到 ,获得积分10
22秒前
清脆代真完成签到,获得积分10
22秒前
Hanoi347完成签到,获得积分0
24秒前
gangxiaxuan完成签到,获得积分10
24秒前
ironsilica完成签到,获得积分10
26秒前
俏皮的绮波完成签到,获得积分10
29秒前
地动完成签到 ,获得积分10
35秒前
于生有你完成签到,获得积分10
38秒前
Ava的应助被科研通管家采纳,获得10
39秒前
老迟到的断秋完成签到,获得积分10
39秒前
YifanWang的应助被科研通管家采纳,获得10
39秒前
彩色的冥茗完成签到,获得积分10
42秒前
43秒前
wang完成签到,获得积分10
45秒前
zxcvbnmgx完成签到 ,获得积分10
46秒前
yulian完成签到,获得积分10
47秒前
冷傲新柔发布了新的文献求助10
49秒前
科研通AI6.4的应助被cfw采纳,获得10
51秒前
kyt_vip完成签到,获得积分10
52秒前
sun完成签到 ,获得积分10
53秒前
wangji_2017完成签到,获得积分10
53秒前
大模型的应助被黑熊精采纳,获得10
54秒前
虚心的紫夏完成签到,获得积分10
54秒前
qwe完成签到,获得积分10
55秒前
英姑的应助被豆豆采纳,获得10
55秒前
1分钟前
qiancib202完成签到,获得积分0
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180053
求助须知:如何正确求助?哪些是违规求助? 9570224
关于积分的说明 21808682
捐赠科研通 7776054
什么是DOI,文献DOI怎么找? 3433261
关于科研通互助平台的介绍 2557425
邀请新用户注册赠送积分活动 2479012